moderna - Search News

News

Moderna sharpens focus on $1.5bn cost cutting plan

Moderna lays off 500 in latest cost-cutting move

The layoffs are part of an ongoing effort to reduce operating costs amid government and competitive challenges to its vaccine business.

Fast Company on MSN · 1d

Moderna is laying off 10% of its workforce. Does RFK Jr. have anything to do with it?

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult decision but necessary step forward,” in an internal memo sent to employees today.

Reuters on MSN · 1d

Moderna plans to lay off 10% of workforce to cut costs

Moderna said on Thursday it would trim roughly 10% of its global workforce and have fewer than 5,000 employees by the end of the year, as the biotech accelerates its cost-cutting efforts amid declining sales of COVID-19 vaccines.

Moderna Logs Sales Beat

The Wall Street Journal on MSN · 22h

Moderna Logs Sales Beat Despite Declining Vaccine Demand

Moderna’s second-quarter sales fell less sharply than Wall Street expected as it works to expand its offerings amid weakening demand for its Covid-19 vaccine.

Fierce Pharma · 18h

Despite ongoing decline, Moderna's Spikevax sales beat expectations in Q2

Despite the overall decline in commercial product revenue, Moderna was also pleasantly surprised by Q2 Spikevax sales, which came in above the company’s expectations thanks to a “stronger-than-expected U.S. spring booster season,” CFO Jamey Mock said on an analyst call Friday.

Boston 25 News on MSN · 1d

Mass.-based Moderna slashing workforce amid declining COVID vaccine sales

Massachusetts-based Moderna announced Thursday that it plans to slash the size of its global workforce by about 10% in the coming months as COVID vaccine sales continue to decline. In a memo that was shared companywide,

21hon MSN

Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by ...

17h

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

17h

Stock Movers: Figma, Moderna, Coinbase

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

15h

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss ...

BioSpace18h

Moderna’s Bancel Nay on M&A, Yay on R&D Partnerships

It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...

13h

Moderna Announces Data to be Presented at ESMO Congress 2025

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...

16hon MSN

Moderna cuts sales forecast on UK revenue delay, shares fall

Moderna trimmed its 2025 revenue forecast on Friday after UK deliveries of some COVID vaccines were deferred to next year, ...

Moderna Inc (MRNA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost ...

Despite a net loss, Moderna Inc (MRNA) showcases resilience with significant cost cuts, new FDA approvals, and a robust cash ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Moderna sharpens focus on $1.5bn cost cutting plan

Moderna Logs Sales Beat

Related topics